CARM1 and Miyoshi myopathy: CARM1 inhibitors, such as EZM2302, resulted in anti-proliferative activity in MM cell lines in vitro and dose-dependent tumor growth inhibition in an MM tumor xenograft model in mice,8 thus revealing a dependency on CARM1 in MM.